Chuck Royce's ANGO Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 1.53 M shares of AngioDynamics, Inc. (ANGO) worth $17.38 M, representing 0.17% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in ANGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 514,935 shares. Largest reduction occurred in Q2 2018, reducing 336,398 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +261,500 | Add 20.63% | 1.53 M | $11.37 |
| Q4 2025 | +272,091 | Add 27.34% | 1.27 M | $12.84 |
| Q3 2025 | +16,800 | Add 1.72% | 995,360 | $11.17 |
| Q2 2025 | -49,070 | Reduce 4.78% | 978,560 | $9.92 |
| Q1 2025 | -91,755 | Reduce 8.20% | 1.03 M | $9.39 |
| Q4 2024 | +133,312 | Add 13.52% | 1.12 M | $9.16 |
| Q3 2024 | +96,138 | Add 10.80% | 986,073 | $7.78 |
| Q2 2024 | +375,000 | Add 72.82% | 889,935 | $6.05 |
| Q1 2024 | +514,935 | New Buy | 514,935 | $5.87 |
| Q4 2020 | -179,225 | Sold Out | 0 | $0.00 |
| Q3 2020 | -174,145 | Reduce 49.28% | 179,225 | $12.06 |
| Q2 2020 | -38,674 | Reduce 9.86% | 353,370 | $10.17 |
| Q1 2020 | -109,855 | Reduce 21.89% | 392,044 | $10.43 |
| Q4 2019 | -102,175 | Reduce 16.91% | 501,899 | $16.01 |
| Q3 2019 | -43,995 | Reduce 6.79% | 604,074 | $18.42 |
| Q2 2019 | -15,476 | Reduce 2.33% | 648,069 | $19.69 |
| Q1 2019 | -92,199 | Reduce 12.20% | 663,545 | $22.86 |
| Q4 2018 | -16,075 | Reduce 2.08% | 755,744 | $20.13 |
| Q3 2018 | -11,591 | Reduce 1.48% | 771,819 | $21.74 |
| Q2 2018 | -336,398 | Reduce 30.04% | 783,410 | $22.24 |
| Q1 2018 | +20,991 | Add 1.91% | 1.12 M | $17.25 |
| Q4 2017 | +133,660 | Add 13.85% | 1.1 M | $16.63 |
| Q3 2017 | +27,009 | Add 2.88% | 965,157 | $17.09 |
| Q2 2017 | +127,836 | Add 15.78% | 938,148 | $16.21 |
| Q1 2017 | +127,764 | Add 18.72% | 810,312 | $17.35 |
| Q4 2016 | -8,061 | Reduce 1.17% | 682,548 | $16.87 |
| Q3 2016 | -61,500 | Reduce 8.18% | 690,609 | $17.54 |
| Q2 2016 | +31,308 | Add 4.34% | 752,109 | $14.37 |
| Q1 2016 | +80,000 | Add 12.48% | 720,801 | $12.29 |
| Q4 2015 | +102,098 | Add 18.95% | 640,801 | $12.14 |
| Q3 2015 | +33,000 | Add 6.53% | 538,703 | $13.19 |
| Q2 2015 | -4,600 | Reduce 0.90% | 505,703 | $16.40 |
| Q1 2015 | -178,028 | Reduce 25.86% | 510,303 | $17.79 |
| Q4 2014 | -160,200 | Reduce 18.88% | 688,331 | $19.01 |
| Q3 2014 | +9,518 | Add 1.13% | 848,531 | $13.72 |
| Q2 2014 | +66,437 | Add 8.60% | 839,013 | $16.33 |
| Q1 2014 | -40,200 | Reduce 4.95% | 772,576 | $15.75 |
| Q4 2013 | -145,627 | Reduce 15.19% | 812,776 | $17.19 |
| Q3 2013 | +12,300 | Add 1.30% | 958,403 | $13.20 |
| Q2 2013 | +946,103 | Add 0.00% | 946,103 | $11.28 |
Chuck Royce's AngioDynamics Investment FAQs
Chuck Royce first purchased AngioDynamics, Inc. (ANGO) in Q2 2013, acquiring 946,103 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held AngioDynamics, Inc. (ANGO) for 40 quarters since Q2 2013.
Chuck Royce's largest addition to AngioDynamics, Inc. (ANGO) was in Q2 2013, adding 946,103 shares worth $10.67 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 1,528,951 shares of AngioDynamics, Inc. (ANGO), valued at approximately $17.38 M.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.17% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in AngioDynamics, Inc. (ANGO) was 1,528,951 shares, as reported at the end of Q1 2026.